Singapore markets open in 1 hour 6 minutes

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5000+0.0500 (+3.45%)
At close: 04:00PM EST
1.5500 +0.05 (+3.33%)
After hours: 04:09PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 61.07M
Enterprise value -41.90M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)7.12
Price/book (mrq)0.72
Enterprise value/revenue -5.82
Enterprise value/EBITDA 0.86

Trading information

Stock price history

Beta (5Y monthly) 2.24
52-week change 347.06%
S&P500 52-week change 315.38%
52-week high 33.5700
52-week low 30.9550
50-day moving average 31.4160
200-day moving average 32.0395

Share statistics

Avg vol (3-month) 3121.97k
Avg vol (10-day) 3107.41k
Shares outstanding 540.71M
Implied shares outstanding 640.71M
Float 812.89M
% held by insiders 10.43%
% held by institutions 185.65%
Shares short (14 Nov 2023) 468.78k
Short ratio (14 Nov 2023) 40.43
Short % of float (14 Nov 2023) 40.21%
Short % of shares outstanding (14 Nov 2023) 40.17%
Shares short (prior month 12 Oct 2023) 423.74k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-444.45%

Management effectiveness

Return on assets (ttm)-31.77%
Return on equity (ttm)-59.95%

Income statement

Revenue (ttm)7.2M
Revenue per share (ttm)0.21
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -52.86M
Net income avi to common (ttm)-49.11M
Diluted EPS (ttm)-1.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)108.03M
Total cash per share (mrq)2.65
Total debt (mrq)5.06M
Total debt/equity (mrq)5.93%
Current ratio (mrq)4.59
Book value per share (mrq)2.10

Cash flow statement

Operating cash flow (ttm)-33.8M
Levered free cash flow (ttm)-17.52M